PrescriptionDrugs.org

What to Expect When Starting Quetiapine

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Quetiapine (Seroquel) is an atypical antipsychotic used to treat schizophrenia, bipolar disorder (manic and depressive episodes), and as an adjunct for major depressive disorder. It works by blocking dopamine and serotonin receptors. Sedation occurs almost immediately and is most pronounced at lower doses. The antipsychotic and mood-stabilizing effects develop over 2-4 weeks. The extended-release formulation (Seroquel XR) allows once-daily dosing.

Week-by-week timeline

Week 1

Starting and Titration

Quetiapine is started low (25-50 mg) and increased over several days to weeks. Sedation is strong and immediate — take at bedtime to use this as a benefit. Dizziness upon standing (orthostatic hypotension) is common. Appetite increases.

Weeks 2-3

Dose Escalation

Dose increases toward the therapeutic range (300-800 mg/day for schizophrenia; 300-600 mg/day for bipolar mania). Sedation may lessen somewhat as the dose increases. Agitation and psychotic symptoms begin to improve.

Weeks 3-6

Antipsychotic Effect

Psychotic symptoms, manic episodes, or depressive symptoms begin to substantially improve. Weight gain and metabolic changes (blood sugar, lipids) begin. Dry mouth, constipation, and blurred vision may occur.

Weeks 6-12

Stabilization

Mood and psychotic symptoms are well-controlled. Metabolic monitoring (weight, blood sugar, lipids) is essential at 12 weeks. Tardive dyskinesia risk is lower than with first-generation antipsychotics but monitoring is still warranted.

Month 3+

Long-Term Monitoring

Annual metabolic panel, fasting glucose, lipids, and weight monitoring. The long-term goal is the lowest effective dose. Discuss any concerns about weight, blood sugar, or movement side effects with your prescriber.

When to call your doctor

Contact your healthcare provider if you experience:

  • Severe dizziness or fainting (orthostatic hypotension — common early in treatment)
  • Neuroleptic malignant syndrome: high fever, muscle rigidity, altered consciousness, sweating
  • Signs of tardive dyskinesia: repetitive involuntary movements of the face, tongue, or limbs
  • Hyperglycemia: extreme thirst, frequent urination, blurred vision, fruity breath
  • Thoughts of self-harm or worsening psychiatric symptoms
  • Severe allergic reaction: difficulty breathing, facial swelling

Tips for getting started

Take quetiapine at bedtime to align sedation with sleep. Rise slowly from bed or chair to prevent fainting from orthostatic hypotension. Monitor your weight weekly and report significant gains. Avoid alcohol as it amplifies sedation. Keep blood sugar and metabolic labs on schedule. Do not stop quetiapine abruptly — taper gradually under medical supervision to avoid withdrawal symptoms including insomnia and rebound symptoms.

Frequently asked questions

More about Quetiapine

References

  1. [Regulatory] FDA Prescribing Information for Seroquel (quetiapine) https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020639s069lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] NIH MedlinePlus: Quetiapine https://medlineplus.gov/druginfo/meds/a698019.html Accessed 2026-03-01.
  3. [Regulatory] NIMH Schizophrenia: Treatment Options https://www.nimh.nih.gov/health/topics/schizophrenia Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: